Jimbos Protocol hacked for $7.5M, JIMBO price drops 40%
The Jimbos Protocol team acknowledged the hack and said it had contacted law enforcement. Blockchain security platform PeckShield noted the attack followed a compromise on...
MASK price spiked10% today: Here’s why
MASK price is up by double digits today and 17% this past two weeks. Most of the gains have come after the team announced it...
Institutions seek detailed blockchain analytics for crypto adoption — Elliptic
As more institutions explore digital assets, the need for on-chain analytics platforms has never been higher. Compliance experts, investigators and regulators employ these blockchain analytical tools...
LTC, ARB and MATIC price outlook amid US debt limit deal
LTC bulls need to break above $93, a key hurdle below the psychological level of $100. MATIC must reclaim $1 to target the $1.30-$1.50 range,...
MakerDAO seeks to increase the DAI savings rate to 3.33%
MakerDAO is considering a proposal to raise the Dai savings rate (DSR). This follows the last change that saw DSR increase to 1%, attracting over...
Beijing releases white paper for Web3 innovation and development
Beijing’s municipal government has unveiled a white paper to foster innovation and advance the Web3 industry.The Zhongguancun Forum witnessed the release of the "Web3 Innovation...
Binance kicks off transition to new platform in Japan
After five years out of the Japanese market, crypto exchange Binance has begun the process of establishing a new and fully regulated subsidiary in the...
Gemini files to dismiss SEC’s lawsuit over its earn product
Gemini Trust Co., a cryptocurrency exchange, and bankrupt lender Genesis Global Capital have jointly filed for the dismissal of a lawsuit brought by the Securities...
A week filled with exploits and uncertainty for DeFi: Finance Redefined
Welcome to Finance Redefined, your weekly dose of essential decentralized finance (DeFi) insights — a newsletter crafted to bring you the most significant developments from...
Neuralink gets FDA approval for ‘in-human’ trials of its brain-computer interface
Elon Musk’s brain-computer interface (BCI) startup, Neuralink, reportedly received approval from the United States Food and Drug Administration (FDA) to conduct some form of “in-human”...